XML 33 R8.htm IDEA: XBRL DOCUMENT
v3.19.3

Certain Balance Sheet Accounts | 9 Months Ended
--- | ---
Sep. 30, 2019
Receivables [Abstract] |
Certain Balance Sheet Accounts | Note 3—Certain Balance Sheet Accounts Accounts Receivable, net Accounts receivable, net consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | December 31,
​ |  | 2019 |  | 2018
​ | ​ | (In thousands)
Trade receivables, net | ​ | $ | 29,809 | ​ | $ | 22,654
Sublease and other receivables | ​ |  | 122 | ​ |  | 164
Total accounts receivables, net | ​ | $ | 29,931 | ​ | $ | 22,818
​ Trade receivables are shown net of $1.5 million and $0.4 million of chargeback and product return allowances as of September 30, 2019 and December 31, 2018, respectively. Inventory Inventory consists of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | December 31,
​ |  | 2019 |  | 2018
​ | ​ | (In thousands)
Raw materials |  | $ | 43 |  | $ | 83
Work-in-progress | ​ |  | 379 | ​ |  | —
Finished goods | ​ |  | 751 | ​ |  | 5
Total inventory |  | $ | 1,173 |  | $ | 88
​ Property and Equipment, Net Property and equipment, net consists of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | December 31,
​ | ​ | 2019 | ​ | 2018
​ | ​ | (In thousands)
Finance leases | ​ | $ | 4,920 | ​ | $ | 4,034
Laboratory equipment | ​ |  | 2,828 | ​ |  | 2,569
Computer equipment | ​ |  | 921 | ​ |  | 862
Office equipment and furniture | ​ |  | 625 | ​ |  | 625
Total cost | ​ |  | 9,294 | ​ |  | 8,090
Less accumulated depreciation and amortization | ​ |  | (5,507) | ​ |  | (4,245)
Total property and equipment, net | ​ | $ | 3,787 | ​ | $ | 3,845
​ For the nine months ended September 30, 2019 and 2018, depreciation and amortization expenses were $1.3 million and $0.7 million, respectively. Accrued Expenses Accrued expenses consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | December 31,
​ | ​ | 2019 | ​ | 2018
​ | ​ | (In thousands)
Contract research and development | ​ | $ | 10,559 | ​ | $ | 12,012
Sales rebates, fees and discounts | ​ |  | 9,691 | ​ |  | 8,075
Interest payable | ​ |  | 4,922 | ​ |  | 1,677
Employee compensation | ​ |  | 3,371 | ​ |  | 2,714
Consulting and professional fees | ​ |  | 3,162 | ​ |  | 3,669
Clinical trials | ​ |  | 1,432 | ​ |  | 820
Other accrued expenses | ​ |  | 859 | ​ |  | 1,219
Total accrued expenses | ​ | $ | 33,996 | ​ | $ | 30,186
​

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration